ANDREA SOLEDAD PAGAN

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology PORT ORANGE, FL NPI 1013428549

General Payments — all program years on this page

$2,123.79

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 38
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $756.34 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $737.1420
Education $19.201

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $590.106
2023 $777.3511
2024 $756.3421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075856187 Celltrion USA Inc. $19.20 09/19/2024 Education Undisputed 01/23/2026 View at CMS
1075856189 Celltrion USA Inc. $21.23 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168928 ABBVIE INC. $124.74 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168930 ABBVIE INC. $16.84 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168932 ABBVIE INC. $0.27 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168934 ABBVIE INC. $24.35 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168936 ABBVIE INC. $20.52 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168938 ABBVIE INC. $14.16 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168940 ABBVIE INC. $25.33 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105168942 ABBVIE INC. $33.05 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113630500 Intercept Pharmaceuticals, Inc. $98.24 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114129550 Regeneron Healthcare Solutions, Inc. $26.49 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117027072 Medtronic, Inc. $165.20 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137647436 Takeda Pharmaceuticals U.S.A., Inc. $15.57 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008590 GENZYME CORPORATION $16.39 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008600 GENZYME CORPORATION $15.59 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144178087 Madrigal Pharmaceuticals $20.93 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144178089 Madrigal Pharmaceuticals $24.23 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147712680 QOL Medical, LLC $22.55 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147712682 QOL Medical, LLC $36.92 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153693126 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.54 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.